Showing 20 of 84 recruiting trials for “sickle-cell-anemia”
SMYLS Multi-site Trial
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
👨⚕️ Robert Nickel, MD, Children's National Research Institute📍 1 site📅 Started Apr 2024View details ↗
Acupressure in Patients With Sickle Cell Disease
Pressure Pain Tolerance in Relation to Balance and Strength in Children
👨⚕️ Shimaa A Ahmed, PHD, Head of Haematology Dept, Faculty of Medicine, Alexandria University📍 1 site📅 Started Feb 2024View details ↗
Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa
👨⚕️ Patrick T McGann, MD, MS, Rhode Island Hospital and Hasbro Children's Hospital📍 1 site📅 Started Nov 2023View details ↗
Sickle Cell Children's Exercise Study (SuCCESs)
A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
Effects of the Contraceptive Implant in Women With Sickle Cell Disease
RecruitingNCT06385886 ↗
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
👨⚕️ Julie Kanter, MD, University of Alabama, Birmingham (UAB)📍 9 sites📅 Started Jun 2023View details ↗
RecruitingNCT05810181 ↗
Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)
👨⚕️ Liza-Marie Johnson, MD, MPH, MSB, St. Jude Children's Research Hospital📍 1 site📅 Started Jun 2023View details ↗
Tocilizumab for Acute Chest Syndrome
RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease
👨⚕️ Ann-Marie Murtagh, King's College Hospitals NHS Foundation Trust📍 1 site📅 Started Feb 2023View details ↗
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
👨⚕️ Maria Cancio, MD, Memorial Sloan Kettering Cancer Center📍 6 sites📅 Started Feb 2023View details ↗
RecruitingNCT05748717 ↗
Arterial Function Parameters and Transcranial Doppler Velocity in Paediatric Patients With Sickle Cell Disease
A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease
PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD
RecruitingNCT05799118 ↗
Study of the Role of Genetic Modifiers in Hemoglobinopathies
👨⚕️ Petros Kountouris, PhD, Cyprus Institute of Neurology and Genetics📍 26 sites📅 Started Oct 2022View details ↗
RecruitingNCT05153967 ↗
Cooperative Assessment of Late Effects for SCD Curative Therapies
👨⚕️ Michael R DeBaun, MD, MPH, Vanderbilt University Medical Center📍 5 sites📅 Started Jul 2022View details ↗
Cognitive Remediation Intervention to Prepare for Transition of Care
RecruitingNCT06250595 ↗
European Rare Blood Disorders Platform (ENROL)
👨⚕️ María del Mar Manú Pereira, PhD, Vall d'Hebron Institut de Recerca / University Hospital Vall d'Hebron (VHIR / HUVH)📍 1 site📅 Started Jul 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →